FTD

FTD GROUP, INC.

FTD

Overview Fund Activity

Delisted

FTD was delisted on the 26th of August, 2008.

Back to rankings

Industrials Specialty Business Services

Financial journalist opinion

Milken Institute SPARC Announces New Funding Programs, Reports, Collaborations to Advance Biomedical Research

WASHINGTON--(BUSINESS WIRE)--The Milken Institute Science Philanthropy Accelerator for Research and Collaboration (SPARC) announced key resources and philanthropic capital to reshape scientific research fields and advance better diagnostics and treatments at the annual Future of Health Summit. Over the last two months, SPARC has worked with philanthropic partners to guide the strategic deployment of nearly $70 million toward neglected research fields, issue four open-access research reports, an.

Milken Institute SPARC Announces New Funding Programs, Reports, Collaborations to Advance Biomedical Research

AviadoBio Announces First Patient Treated in ASPIRE-FTD Clinical Trial Evaluating AVB-101 for Frontotemporal Dementia with GRN Mutations

LONDON--(BUSINESS WIRE)--AviadoBio, a pioneering gene therapy company dedicated to developing and delivering potentially transformative medicines for neurodegenerative disorders, today announced that the first patient has been treated in the Phase 1/2 ASPIRE-FTD trial evaluating AviadoBio's investigational gene therapy, AVB-101, in people with frontotemporal dementia (FTD) with progranulin (GRN) gene mutations (FTD-GRN). Clinical trial sites are currently open in Poland, Spain, and the Netherla.

AviadoBio Announces First Patient Treated in ASPIRE-FTD Clinical Trial Evaluating AVB-101 for Frontotemporal Dementia with GRN Mutations

See News Rankings

Charts implemented using Lightweight Charts™